Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

495 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SARS-CoV-2 infection triggering a giant cell arteritis.
Riera-Martí N, Romaní J, Calvet J. Riera-Martí N, et al. Among authors: calvet j. Med Clin (Engl Ed). 2021 Mar 12;156(5):253-254. doi: 10.1016/j.medcle.2020.11.008. Epub 2021 Mar 11. Med Clin (Engl Ed). 2021. PMID: 33723520 Free PMC article. No abstract available.
SARS-CoV-2 infection triggering a giant cell arteritis.
Riera-Martí N, Romaní J, Calvet J. Riera-Martí N, et al. Among authors: calvet j. Med Clin (Barc). 2021 Mar 12;156(5):253-254. doi: 10.1016/j.medcli.2020.11.005. Epub 2020 Dec 3. Med Clin (Barc). 2021. PMID: 33384146 Free PMC article. No abstract available.
Real-world adalimumab survival and discontinuation factors in hidradenitis suppurativa.
Garbayo-Salmons P, Vilarrasa E, Bassas-Vila J, Mora-Fernández V, Fuertes I, Luque-Luna M, Fornons-Servent R, Martin-Ezquerra G, Aguayo-Ortiz RS, Ceravalls J, Mollet J, Gómez Tomás Á, Masferrer E, Corral-Magaña O, Matas-Nadal C, Del Estal J, Fuertes Bailón D, Calvet J, Romaní J. Garbayo-Salmons P, et al. Among authors: calvet j. J Eur Acad Dermatol Venereol. 2024 Apr 30. doi: 10.1111/jdv.20044. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38687278
Glucocorticoids' treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients.
Garcia-Cirera S, Calvet J, Berenguer-Llergo A, Pradenas E, Marfil S, Massanella M, Mateu L, Trinité B, Llop M, Arévalo M, Galisteo C, Orellana C, Gómez R, Gómez-Gerique MN, Carmona I, Clotet B, Blanco J, Gratacós J. Garcia-Cirera S, et al. Among authors: calvet j. Sci Rep. 2022 Aug 30;12(1):14772. doi: 10.1038/s41598-022-18996-x. Sci Rep. 2022. PMID: 36042275 Free PMC article.
Validation of N Protein Antibodies to Diagnose Previous SARS-CoV-2 Infection in a Large Cohort of Healthcare Workers: Use of Roche Elecsys® Immunoassay in the S Protein Vaccination Era.
Delgado JF, Vidal M, Julià G, Navarro G, Serrano RM, van den Eynde E, Navarro M, Calvet J, Gratacós J, Espasa M, Peña P. Delgado JF, et al. Among authors: calvet j. Viruses. 2023 Apr 7;15(4):930. doi: 10.3390/v15040930. Viruses. 2023. PMID: 37112910 Free PMC article.
Biological and glucocorticoids treatment impair the medium-term immunogenicity to SARS-CoV-2 mRNA vaccines in autoimmune inflammatory rheumatic diseases.
Garcia-Cirera S, Calvet J, Delgado de la Poza JF, Berenguer-Llergo A, Orellana C, Rusiñol M, Llop M, Arévalo M, Garcia-Pinilla A, Costa E, Aymerich C, Gómez R, Carreras A, Gratacós J. Garcia-Cirera S, et al. Among authors: calvet j. Eur J Med Res. 2024 Jan 5;29(1):28. doi: 10.1186/s40001-023-01620-7. Eur J Med Res. 2024. PMID: 38183092 Free PMC article.
495 results